Form EFFECT Y-mAbs Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 16, 2025 |
| Accession Number: | 0001104659-25-090236 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 74Software: Disclosure of transactions in own shares from July 6 to 10, 2026
- Japan Government, Industrial Leaders and NVIDIA Launch the World’s First National AI Infrastructure
- Santos Muscle Nutrition to Showcase Dutch Sports Nutrition at September Retail Meetings
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
